different posttranslational modification may also modulate the activity of PARPs (for review see [7, 8] ).
PAR molecules can be joined onto PARP-1 or PARP-2 (autoPARylation) or onto other acceptor molecules (transPARylation). AutoPARylation inhibits PARP-1 activation and therefore inhibit PARP-1 overactivation, while removing PAR reactivates PARP-1 [5] . The PAR polymer is rapidly degraded in cells to ADPR. There are several enzymes capable of degrading PAR, such as poly(ADP-ribose) glycohydrolase (PARG) ADP-ribosyl-acceptor hydrolase 3 (ARH3), ADP-ribosyl lyase and macrodomain-containing proteins [8] . Poly(ADP-ribose) glycohydrolase (PARG) removes PAR reverting and reactivating PARP-1. ADPR can be further fragmented to AMP by Nucleoside Diphosphate Linked to X (NUDIX) pyrophosphatases; increases in cellular AMP has pivotal role in mitochondrial deterioration inflicted by PARP activation [8] .
PARPs are involved in a plethora of biological processes, hereby -due to space limitations -we refer the reader to reviews [4, 9] .
Primary events of aging

Genomic instability and telomere attrition
Accumulating genetic damage during aging is unavoidable as genomic material is continuously challenged by exogenous (physical, chemical and biological) and endogenous (replication errors, hydrolytic reactions and oxidative damage) factors [10] . In order to maintain genetic integrity, a vast repertoire of DNA repair mechanisms stand ready to prevent DNA damage and accumulation of these lesions over time. It seems more likely that genomic instability during aging is rather a consequence of declined or impaired repair functions [10] .
Should repair mechanisms fail, cells undergo apoptosis or suffer senescence as a tumor suppression mechanism.
Many DNA repair mechanisms, counteracting the above-detailed changes, are PARPdependent processes. PARP-1, PARP-2 and PARP-3 were shown to be activated by DNA strand breaks [11] . PARPs have role in nucleotide excision repair to attack bulky adducts, base excision repair processes to counteract base modifications and in the repair of single and double strand breaks (both non-homologous end joining and homologous repair) and to maintain genomic integrity [11] . The deletion or pharmacological inhibition of PARP-1, PARP-2 or PARP-3 does not lead to spontaneous genomic instability [11, 12] , however, under genotoxic stress the loss of PARPs does lead to genomic instability [11] . In line with these observations, the simultaneous deletion of PARP-1 and PARP-2 or PARPs and other DNA repair enzymes lead to embryonic lethality that is characterized by the accumulation of DNA damage [11] .
There are specific regions of the genome that seem to be more prone to DNA damage. Telomeres, affected especially by age related shortening, are among these regions [13] . In somatic human cells, telomeres shorten with every round of replication and cells are triggered into replicative senescence once telomeres shorten to a critical length [13] . Telomeres can be rebuilt by the enzyme telomerase that has cofactors, such as telomeric repeat binding factor 1 and 2 (TRF1 and TRF2, respectively) [13] .
PARP-1, TNK1 and TNK2 are involved in telomere maintenance through different mechanisms. TNKs interact with TRF1 (but not TRF2) and both are localized together near the physical ends of metaphase chromosomes, implying TNKs as a components of the human telomeric complex [14] . TNKs have intrinsic PARP activity towards at least two substrates (TRF1 and themselves) [14] resulting in decreased binding of TRF1 to telomeres and induces proteasome-mediated degradation of TRF1, hence TRF1 is a negative regulator of telomere length [15] . In addition to TNKs, PARP-1 is also involved in telomere maintenance, wherein PARP-1 is a negative regulator of TRF2 [16] . Indeed, the absence of PARP-1 did lead to dramatically shortened telomeres in PARP-1 -/-mice and cells [17, 18] and in such cells chromosomes are prone to end-to-end fusions [19] .
Muiras and Bürkle [2, [20] [21] [22] has linked better DNA repair capabilities upon higher total PARP activity with prolonged lifespan. Indeed, in centenarians, who actually aged successfully, higher PARP-1 activity was detected as compared the average of population [2] .
Indeed, a subsequent study by Mangerich and co-workers [23] showed that the overexpression of an extra copy of PARP-1 in mice reduced the incidence of several malignant diseases clearly validating the original observations of Muiras [2] .
Epigenetic alterations and changes in gene expression
Epigenetics has been defined as the inheritance of changes in gene function without any change in the DNA nucleotide sequence. A variety of epigenetic alterations including posttranslational histone modifications and chromatin remodeling could be associated to influence aging [24] . PARP-1, PARP-2 and TNK1 were shown to modulate chromatin structure, to mediate both condensation and decondensation events and hence play indispensable role in establishing facultative and constitutive heterochromatin (Barr body, centrosome, pericentrosome, telomere, inactivated sex chromosome during meiosis, inactive rRNA genes, etc.) [25] . Moreover, PARP-1 impacts on epigenetic marks by PARylating histones and chromatin remodeling enzymes such as KDM5B, ISWI, ALC1, DNMT-1, CTCF etc. (for review see [26] ) or can rearrange nucleosome and linker histone binding through which PARP-1 influences transcription [26] . PARP-1 binds to 90% of the Pol II-transcribed genes and mediates around 3.5% of all transcribed RNAs [26] . Besides PARP-1, PARP-2, -7, -10, -14 regulates gene expression [4] . It is not yet fully confirmed by experimental data, however it is likely that the modulation of epigenetic factors by PARPs could impact on aging.
Loss of proteostasis
Proteostasis means the maintenance of protein turnover and functional proteins in all cellular compartments. Different forms of stress have an impact on the cell proteome which uses a vast number of protein stabilization and refolding mechanisms (via heat-shock proteins)
to maintain the functionality of affected proteins. If proteins can't be rescued, the incorrectly folded structures are targeted for lysosomal or proteasomal degradation to avoid their accumulation and aggregation [1] . Dysfunctional proteostasis is associated with aging and age related diseases like Alzheimer's or Parkinson's disease [1] .
Overloading the protein translation machinery leads to the production of misfolded proteins that declutches a signaling mechanism called ER stress that slows down protein synthesis to enable cells to cope with misfolded, dysfunctional proteins. PARP-1 has regulatory role in translation [27] , moreover, PARP-1 has a role in ER-stress signaling [28] .
Upon oxidative stress the 20S proteasome in the nucleus is rapidly activated in a PARP-1 and PARylation-dependent fashion [29] [30] [31] [32] that is closely linked to reduced rate of aging, increased proliferative capacity and tumor growth [33, 34] . In contrast to that, genetic or pharmacological inhibition of PARP-1 reduce proteolytic activity and induce senescence [35] [36] [37] [38] .
Proteostasis is not limited to the removal of damaged proteins, but to the preservation of the balance between the protein content or protein composition between cellular organelles such as the balance between mitochondrial and nuclear proteins [39] . The regulatory circuit balancing between mitochondrial and nuclear protein pools is comprised of two arches. Energy stress sensor pathways (e.g. SIRT1, AMPK, etc.) help in translating shortcomings in cellular energetics into nuclear transcription programs that then upregulate mitochondrial energy production. The other arch is called retrograde signaling translating mitochondrial dysfunction (e.g. decreased expression or function of complex I) into nuclear transcriptional programs that can restore mitochondrial oxidation [39] . The activation of PARP-1 had been shown to influence mitonuclear protein balance through modulating SIRT1 activity [40] .
Mitochondrial dysfunction
Mitochondrial oxidation capacity deteriorates on the course of aging [1] . The negative effect of PARP-1 on mitochondrial activity was described in 1998 by Virág and co-workers [41] .
PARP-1 overactivation blunts mitochondrial activity through several parallel pathways (for comprehensive review see [8, 42] ): 1) inhibition of mitotropic transcription factors (e.g. SIRT1) [5, 43] , 2) induction of transcription factors that suppress mitochondrial activity (e.g. HIFs) [44, 45] , 3) inhibiting mitochondrial membrane and membrane-associated enzymes (e.g. ANT, the hexokinase-ANT complex) by cytosolic PAR polymers [8, 46, 47] , 4) impairs mitophagy and nuclear-mitochondrial protein balance [40, 48] .
In contrast, the deletion or pharmacological inhibition of PARP-1 or PARP-2 enhances mitochondrial activity through inducing SIRT1 activity by enhancing cellular NAD + levels or by inducing SIRT1 expression, respectively [5, 40] . Enhanced SIRT1 activity leads to the deacetylation of mitotropic transcription factors, such as FOXO1 or PGC-1α that induce transcription programs that support mitochondrial oxidative metabolism [5, 40] . PARPs interact with energy sensor (e.g. AMPK, NRFs, SIRT3 -for review see [8] ), however, the involvement of these pathways in PARP-mediated changes in mitochondrial activity is poorly characterized.
The balance between SIRT1 and PARP-1 has central role in setting the rate of mitochondrial oxidative metabolism. Both enzyme use a common substrate, NAD + and can limit each other's activity [5] . Several elegant studies from Braidy and co-workers (e.g. [49, 50] )
have shown that the activity of PARP-1 enhances upon aging that reduces cellular NAD + levels and consequently SIRT1 activity that blunts mitochondrial oxidation. Importantly, mitochondrial biogenesis -most probably in the skeletal muscle -upon the deletion of PARP-1 or PARP-2 protect against type II. diabetes that is a classical aging-related metabolic disease [12] . In line with these findings the overexpression of PARP-1 in mice leads to type II. diabetes [23] . There are other PARPs with metabolic properties [12] suggesting that these enzymes may also participate in the metabolic rearrangements in aging.
Deregulated nutrient sensing
Nutrient availability defines the balance between anabolism and catabolism, moreover it is involved in the regulation of key aging-related processes, such as autophagy, cell divisions, hormonal signaling, diurnal rhythms, calorie restriction, etc. The systems that are involved in nutrient sensing are often referred as energy (stress) sensor pathways [51] and involveamong others -the AMPK-mTOR system, nuclear receptors or hormonal signaling. These sensor systems can be pharmacologically modulated to mimic dietary changes that modulate lifespan and healthspan (e.g. calorie restriction) [51] .
The deletion of PARP-1 in mice led to perturbed diurnal rhythm and increased food uptake and negative energy balance [12] suggesting dysfunction of the central (hypothalamic) circadian regulation. Although direct molecular proofs are missing for the defects of central regulation, hepatic (i.e. peripheral) circadian oscillations are perturbed upon the pharmacological inhibition or the deletion of PARP-1 due to the absence of the PARylation of CLOCK protein and the consequent dysregulation of the CLOCK-BMAL/PER-CRY circuitry [52] .
PARP activity responds to nutrient availability, in skeletal muscle autoPARylation and protein level of PARP-1 increased upon feeding mice with hypercaloric high fat diet, while fasting sharply reduced PARP-1 activity [12] . As an extension to that, several nutrient sensor pathways were shown to be mediated by PARP-1. PARP-1 influences the phophatidil-inositol-3 kinase (PI3K)-Akt and glucagon-like peptide (GLP)-1 pathway through which PARP-1 mediates insulin (and probably growth factor) signaling [53] [54] [55] [56] . There are numerous examples where PARPs interact with nuclear receptors and hence mediate sensing intra or extracellular lipid levels [8] . The impact of the interactions between PARP-1 and energy sensors (AMPK, mTORC1, NRFs, HIFs, SIRTs -see also the previous chapter and [4, 8] ) on nutrient sensing had not been assessed. Taken together, the current data suggest that PARP-1 influences both central and peripheral sensing of lipids, glucose and amino acids. Little is known about PARPs other than PARP-1, primarily due to the lack of dedicated in vivo studies, however, PARP-2 is known to interplay with beta cell function and certain nuclear receptors [57] , while tankyrases impact on beta cell function and feeding [58] .
Integrative events of ageing
Stem cell exhaustion
With the progress of aging it is very common for different tissues to have an impaired regenerative ability due to compromised stem cell renewal capacity [1] . Importantly, PARP-1 and PARP-7 define in stem cells whether cells undergo terminal differentiation or renewal [59] .
PARP-2 activity had been also linked with sustaining hematopoietic stem cell (HSC) production [60, 61] or thymopoiesis [62] .The application of PARP inhibitors, mostly through inhibiting PARP-1, influence the differentiation of bone marrow-derived cells, neurons, spermatocytes, skeletal muscle, osteoblasts and adipocytes [4] . Although it is very likely that PARP activation may alter the renewing capacity of stem cells, yet, direct evidences are missing.
Cellular senescence
A hallmark of cellular senescence is the slowdown or complete stop of cell cycle [1] .
PARylation levels change on the course of the cell cycle [4] , being the highest in G2 and S phase, while the lowest in G1 that is probably linked to DNA repair. The degradation of PAR or TNK1 silencing leads to a pre-anaphase block, PARP-1 is required for primase activity and replication-coupled repair and its absence leads to G2/M arrest when genotoxic stress is present. PARP-6 is necessary to leave the S-phase, while PARP-3 regulates the G1 to S phase progression. Taken together, PARPs are required for sustaining the progression of cell cycle.
Compromised intercellular communication
There are several modalities of communication between cells of an organism, the hormones of the endocrine system, cytokines or chemokines, etc. Although our knowledge is limited on the endocrine functions of PARPs, it is clear that PARPs are involved in the function of pancreatic beta cells [12] or different peptide hormones, among them several adipokines ( Fig. 1 . and [63, 64] ). The involvement of PARP-1 in the age related changes in insulin secretion and the consequent appearance of type II. diabetes was suggested by Mangerich et al. [23] , pointing towards the possibility of other PARP-mediated, age-related endocrine changes.
Ageing-related changes in the inflammatory system involve inflammaging. In inflammaging the normal function of the immune system is compromised: on the one hand, low grade inflammation commences in tissues (e.g. white adipose tissue) that on the long run deteriorates the function of these tissues, while on the other, the elimination of pathogens is limited. PARP-1 and PARP-2 control the expression of a plethora of chemokines, cytokines, inducible nitric oxide synthase (iNOS) and polyunsaturated fatty acids and exert proinflammatory roles in Th1 and Th2-mediated pathologies [65, 66] . It is tempting to speculate that ageing-related enhancement of PARP activity may feed-forward the low grade inflammation that accompanies inflammaging. Furthermore, PARP-1 and PARP-2 plays role in free radical-induced cell death that often accompany inflammation (also called a bystander effect) [4, 42] adding another modality to the pro-aging role for these enzymes. It must be noted that there are anti-inflammatory PARPs as well (e.g. tankyrases), however the role of these PARPs in aging is completely unknown. Finally, PARP-1 regulates endothelial NOS function and the production of oxygen-centered reactive species (e.g. mitochondrial uncoupling) through which it impacts on the function of gaseotransmitters [67] .
Conclusions
Since the first pioneering observation, where higher PARP-1 expression was found in centenarians [2] that was linked to improved DNA damage sensing and more efficient repair, a way more complex picture was obtained on the role of PARPs in aging. PARP-1 and, to a smaller extent, PARP-2 are key factors in aging-related diseases (neurodegenerative diseases, metabolic diseases, etc.) [4] , finally the competing nature of the anti-aging action of PARP-1 and PARP-2 (maintaining DNA integrity) and the pro-aging actions (increased susceptibility to metabolic diseases) was discovered [23] (see graphical abstract). In other words, PARP activation is a double-edged sword in aging, while enhanced PARP activity ensures DNA integrity, PARP activation at the same time makes the organism more susceptible to metabolic diseases [23] . 
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